Pharma Firm
- All
- News
- Videos
-
Licence Of Tamil Nadu Firm Behind 'Killer' Cough Syrup Revoked
The Tamil Nadu Drug Control department has revoked the complete licence of Sresan Pharma, which manufactured 'Coldrif' cough syrup that led to the deaths of several children across India.
-
Coldrif Cough Syrup Deaths: Pharma Firm Owner Sent To 10-Day Police Custody
A Parasia court on Friday sent Sresan Pharma owner Ranganathan to 10-day police custody in connection with the deaths of children allegedly caused by the consumption of Coldrif cough syrup.
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
-
Firm Behind Cough Syrup Linked To Child Deaths Under Scanner In Rajasthan
The company whose cough syrup has been linked to three deaths and a doctor losing consciousness in Rajasthan is now under the state government's scanner.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Warns Pharma Companies To Cut Prices Or Be Punished
US President Donald Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world.
-
"Could Have Been...": Russia Denies Attack On Indian Firm's Kyiv Warehouse
Russia has refuted allegations by Ukraine that a Russian missile struck the warehouse of an Indian pharma firm in Kyiv last week.
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
Chandrababu Naidu Stresses Workplace Safety After Andhra Pharma Firm Blast
Workplace safety - particularly in 'red category' industries, or those that deal with hazardous materials and have a pollution index over 60 - must go hand-in-hand with investment in the state, Andhra Pradesh Chief Minister N Chandrababu Naidu said.
-
Clinical Research Firm for Nykaa, FirstCry Partners Qila.io to Receive Blockchain Revamp
Clinical research centre Mascot Spincontrol and blockchain firm Qila has collaborated to keep the integrity of medical research work intact with secure and tamper-proof data storage. Blockchain technology prevents the concentration of data in one location, making it difficult for hackers or other malicious agents to manipulate the stored informatio...
-
K Kavitha "Threatened" Pharma Firm Boss To Pay Rs 25 Crore To AAP: CBI To Court
CBI told a special court here that BRS leader K Kavitha allegedly "threatened" Aurobindo Pharma promoter Sharath Chandra Reddy to pay an amount of Rs 25 crore to the AAP for the five retail zones allotted to his firm under the Delhi excise policy.
-
Licence Of Tamil Nadu Firm Behind 'Killer' Cough Syrup Revoked
The Tamil Nadu Drug Control department has revoked the complete licence of Sresan Pharma, which manufactured 'Coldrif' cough syrup that led to the deaths of several children across India.
-
Coldrif Cough Syrup Deaths: Pharma Firm Owner Sent To 10-Day Police Custody
A Parasia court on Friday sent Sresan Pharma owner Ranganathan to 10-day police custody in connection with the deaths of children allegedly caused by the consumption of Coldrif cough syrup.
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
-
Firm Behind Cough Syrup Linked To Child Deaths Under Scanner In Rajasthan
The company whose cough syrup has been linked to three deaths and a doctor losing consciousness in Rajasthan is now under the state government's scanner.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Warns Pharma Companies To Cut Prices Or Be Punished
US President Donald Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world.
-
"Could Have Been...": Russia Denies Attack On Indian Firm's Kyiv Warehouse
Russia has refuted allegations by Ukraine that a Russian missile struck the warehouse of an Indian pharma firm in Kyiv last week.
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
Chandrababu Naidu Stresses Workplace Safety After Andhra Pharma Firm Blast
Workplace safety - particularly in 'red category' industries, or those that deal with hazardous materials and have a pollution index over 60 - must go hand-in-hand with investment in the state, Andhra Pradesh Chief Minister N Chandrababu Naidu said.
-
Clinical Research Firm for Nykaa, FirstCry Partners Qila.io to Receive Blockchain Revamp
Clinical research centre Mascot Spincontrol and blockchain firm Qila has collaborated to keep the integrity of medical research work intact with secure and tamper-proof data storage. Blockchain technology prevents the concentration of data in one location, making it difficult for hackers or other malicious agents to manipulate the stored informatio...
-
K Kavitha "Threatened" Pharma Firm Boss To Pay Rs 25 Crore To AAP: CBI To Court
CBI told a special court here that BRS leader K Kavitha allegedly "threatened" Aurobindo Pharma promoter Sharath Chandra Reddy to pay an amount of Rs 25 crore to the AAP for the five retail zones allotted to his firm under the Delhi excise policy.
